The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Insurance, Health, Reimbursement

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Insurance, Health, Reimbursement

  • The objective of this study was to project the effect of losartan compared to placebo on the lifetime incidence of ESRD and associated costs from a third-party payer perspective in Mexico. METHODS: A competing risks method was used to estimate lifetime incidence of ESRD, while accounting for the risk of death without ESRD [1].

High impact information on Insurance, Health, Reimbursement


Associations of Insurance, Health, Reimbursement with chemical compounds


Gene context of Insurance, Health, Reimbursement

  • Alteplase had acceptable cost-effectiveness ratios compared with conventional therapy and streptokinase therapy from both third-party payer and hospital perspectives [12].
  • A growing body of literature, primarily published in the United States, has demonstrated that ADHD places a substantial economic burden on patients, families, and third-party payers [13].
  • Use of GH for idiopathic short stature in clinical practice will depend on its efficacy in promoting growth and the value of this effect to families, physicians, and third-party payers [14].
  • Discrepancies should be resolved between maternal PKU medical recommendations and the policies of third party-payers [15].
  • Nevertheless, DRG-based payment systems are being adopted by State Medicaid agencies and private third-party payers, and the Health Care Financing Administration has been mandated to report to Congress on the feasibility of including children's hospitals in the Federal PPS [16].

Analytical, diagnostic and therapeutic context of Insurance, Health, Reimbursement


  1. The impact of losartan on the lifetime incidence of ESRD and costs in Mexico. Arredondo, A., Burke, T.A., Carides, G.W., Lemus, E., Querol, J. Rev. Invest. Clin. (2005) [Pubmed]
  2. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-year database. Adams, P.C., Gregor, J.C., Kertesz, A.E., Valberg, L.S. Gastroenterology (1995) [Pubmed]
  3. The cost-effectiveness of sildenafil. Smith, K.J., Roberts, M.S. Ann. Intern. Med. (2000) [Pubmed]
  4. Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Bapat, B., Noorani, H., Cohen, Z., Berk, T., Mitri, A., Gallie, B., Pritzker, K., Gallinger, S., Detsky, A.S. Gut (1999) [Pubmed]
  5. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists. Creticos, P.S. Drugs (2003) [Pubmed]
  6. Consumer-driven health care: just a tweak or a revolution? Scandlen, G. Health affairs (Project Hope) (2005) [Pubmed]
  7. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Dubinsky, M.C., Reyes, E., Ofman, J., Chiou, C.F., Wade, S., Sandborn, W.J. Am. J. Gastroenterol. (2005) [Pubmed]
  8. Benzodiazepine tranquilizers and the risk of accidental injury. Oster, G., Huse, D.M., Adams, S.F., Imbimbo, J., Russell, M.W. American journal of public health. (1990) [Pubmed]
  9. Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Thistlethwaite, J.R., Haag, B.W., Jones, K.W., Stuart, J.K., Stuart, F.P. Hum. Immunol. (1985) [Pubmed]
  10. A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study. Marchetti, A., LaPensee, K., An, P. Clinical therapeutics. (1998) [Pubmed]
  11. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma. Volmer, T., Kielhorn, A., Weber, H.H., Wiessmann, K.J. PharmacoEconomics. (1999) [Pubmed]
  12. Alteplase: a pharmacoeconomic evaluation of its use in the management of myocardial infarction. Barradell, L.B., Goa, K.L. PharmacoEconomics. (1995) [Pubmed]
  13. A review of the economic burden of ADHD. Matza, L.S., Paramore, C., Prasad, M. Cost effectiveness and resource allocation [electronic resource] : C/E. (2005) [Pubmed]
  14. Effect of growth hormone therapy on height in children with idiopathic short stature: a meta-analysis. Finkelstein, B.S., Imperiale, T.F., Speroff, T., Marrero, U., Radcliffe, D.J., Cuttler, L. Archives of pediatrics & adolescent medicine. (2002) [Pubmed]
  15. Barriers to successful dietary control among pregnant women with phenylketonuria. Brown, A.S., Fernhoff, P.M., Waisbren, S.E., Frazier, D.M., Singh, R., Rohr, F., Morris, J.M., Kenneson, A., MacDonald, P., Gwinn, M., Honein, M., Rasmussen, S.A. Genet. Med. (2002) [Pubmed]
  16. Policy issues related to prospective payment for pediatric hospitalization. Payne, S.M., Restuccia, J.D. Health care financing review. (1987) [Pubmed]
  17. Home parenteral nutrition: a hospital-based program with commercial logistic support. Wesley, J.R., Khalidi, N., Faubion, W.C., Ryan, M.L., de Leon, R.F. JPEN. Journal of parenteral and enteral nutrition. (1984) [Pubmed]
  18. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective. de Lissovoy, G., Subedi, P. The American journal of managed care. (2002) [Pubmed]
WikiGenes - Universities